Fingerprint
Dive into the research topics of 'Five Year Survival Update From KEYNOTE-010: Pembrolizumab Versus Docetaxel for Previously Treated, Programmed Death-Ligand 1–Positive Advanced NSCLC'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically